WG
BIVI icon

Winton Group’s BioVie BIVI Stock Holding History

Winton Group’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-297
Closed -$128K – 776
2023
Q2 		$128K Buy
+297
New +$200K 0.01% 699

Other funds holding BIVI

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winton Group's BIVI Position: Q3 2023 in Review

Winton Group sold out of BioVie (BIVI) in Q3 2023, closing a stake of 297 shares — an estimated $128K sold.

Winton Group first reported a position in BIVI in Q2 2023 and held it in 1 quarter. The position peaked at $128K in Q2 2023. 56 funds tracked by Wall St. Rank hold BIVI as of Q3 2023.

  • Winton Group reported no remaining BioVie position as of Q3 2023 after selling out during the quarter.
  • Winton Group sold 297 BioVie shares in Q3 2023, an estimated $128K.
  • Winton Group first reported a position in BioVie in Q2 2023 and held it in 1 quarter.
  • Winton Group's BioVie position peaked at $128K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held BioVie as of Q3 2023.

Based on Winton Group's 13F filing for Q3 2023, filed 13 Nov 2023.